Preliminary evidence on safety and clinical efficacy of luteolin for patients with prostate cancer

被引：0
|
作者：
Naiki, Aya [1 ]
Naiki, Taku [1 ,2 ]
Murakami, Akihiro [1 ]
Kato, Hiroyuki [1 ]
Takahashi, Satoru [1 ]
机构：
[1] Nagoya City Univ, Dept Exp Pathol Tumor Biol, Nagoya, Aichi, Japan
[2] Nagoya City Univ, Dept Nephrourol, Nagoya, Aichi, Japan
来源：
CANCER SCIENCE | 2025年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J-3029
引用
收藏
页码：1368 / 1368
页数：1
相关论文
共 50 条
  • [21] Safety and efficacy of an implantable leuprolide delivery system in patients with advanced prostate cancer
    Fowler, JE
    Gottesman, JE
    Reid, CF
    Andriole, GL
    Soloway, MS
    JOURNAL OF UROLOGY, 2000, 164 (03): : 730 - 734
  • [22] Safety and efficacy of cabazitaxel in Japanese patients with castration-resistant prostate cancer
    Yamamoto, Teppei
    Ishizuka, Osamu
    Oike, Hiroshi
    Shiozaki, Masashi
    Haba, Tomomi
    Oguchi, Tomohiko
    Iijima, Kazuyoshi
    Kato, Haruaki
    PROSTATE INTERNATIONAL, 2020, 8 (01) : 27 - 33
  • [23] Phase I/II clinical trial of 177Lu-DGUL in metastatic castration-resistant prostate cancer patients: preliminary results of safety, dosimetry, and efficacy
    Suh, Minseok
    Cheon, Gi Jeong
    Kang, Keon Wook
    Jeong, Jae Min
    Seo, Hee Jeong
    Jeong, Bora
    Jeong, Chang Wook
    Kwak, Cheol
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [24] Initial evaluation of the clinical efficacy and safety of enzalutamide in castration-resistant prostate cancer
    Miura, Noriyoshi
    Kakuta, Toshio
    Noda, Terutaka
    Asai, Seiji
    Fukumoto, Tetsuya
    Yanagihara, Yutaka
    Miyauchi, Yuki
    Kikugawa, Tadahiko
    Tanji, Nozomu
    Yokoyama, Masayoshi
    ANNALS OF ONCOLOGY, 2015, 26 : 145 - 145
  • [25] Clinical pharmacokinetics, safety, and preliminary efficacy evaluation of icotinib in patients with advanced non-small cell lung cancer
    Liu, Dongyang
    Zhang, Li
    Wu, Yiwen
    Jiang, Ji
    Tan, Fenlai
    Wang, Yingxiang
    Liu, Yong
    Hu, Pei
    LUNG CANCER, 2015, 89 (03) : 262 - 267
  • [26] Safety and clinical efficacy of a new 6-month depot formulation of leuprorelin acetate in patients with prostate cancer in Europe
    U W Tunn
    K Wiedey
    Prostate Cancer and Prostatic Diseases, 2009, 12 : 83 - 87
  • [27] Safety and clinical efficacy of a new 6-month depot formulation of leuprorelin acetate in patients with prostate cancer in Europe
    Tunn, U. W.
    Wiedey, K.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2009, 12 (01) : 83 - 87
  • [28] Efficacy and safety of therapies for advanced prostate cancer in Asia: Evidence from a systematic literature review
    Saad, Marniza
    Umbas, Rainy
    Chiong, Edmund
    Kanesvaran, Ravindran
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [29] Clinical efficacy and safety of cefepime in febrile neutropenic patients with lung cancer
    Fujita, Masaki
    Ouchi, Hiroshi
    Inoue, Yuichi
    Inoshima, Ichiro
    Ohshima, Tsukasa
    Yoshimura, Chikara
    Wataya, Hiroshi
    Kawasaki, Masayuki
    Tokunaga, Shoji
    Nakanishi, Yoichi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2010, 16 (02) : 113 - 117
  • [30] SAFETY AND EFFICACY OF ERASER LASER ENUCLEATION OF THE PROSTATE (ELEP), PRELIMINARY REPORT
    Lusuardi, Lukas
    Myatt, Andrew
    Sieberer, Manuela
    Jeschke, Stephan
    Zimmermann, Reinhold
    Hruby, Stephan
    Janetschek, Guenter
    JOURNAL OF ENDOUROLOGY, 2011, 25 : A196 - A196
12345